ERCP and Related Technologies: A Clinical Update

David L. Carr-Locke, MD, FRCP, FACG, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.


May 22, 2000

In This Article

1999 Review of the Literature

The following compilation of articles was produced by Dr. Carr-Locke.

Brand B, Thonke F, Obytz S, Binmoeller F, et al. Stent retriever for dilation of pancreatic and bile duct strictures. Endoscopy. 1999;31:142-145.

Cortas GA, Mehta SN, Abraham NS, Barkum AN. Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes. Gastrointest Endosc. 1999;50:775-779.

Faylona JMV, Qadir A, Chan ACW, Lau JYW, Chung SCS. Small-bowel perforations related to endoscopic retrograde cholangiopancreatography (ERCP) in patients with Billroth II gastrectomy. Endoscopy. 1999;31:546-549.

Goff JS. Long-term experience with the transpancreatic sphincter pre-cut approach to biliary sphincterotomy. Gastrointest Endosc. 1999;50:642-645.

Graber RG. Propofol in the endoscopy suite: an anesthesiologist's perspective. Gastrointest Endosc. 1999;49:803-806.

Kodama T, Sato H, Horli Y, et al. Pancreatoscopy for the next generation: development of the peroral electronic pancreatoscope system. Gastrointest Endosc. 1999;49:366-371.

Kozarek RA, Raltz SL, Ball TJ, Patterson DJ, Brandabur JJ. Reuse of disposable sphincterotomes for diagnostic and therapeutic ERCP: a one-year prospective study. Gastrointest Endosc. 1999;49:39-42.

Kozarek RA, Raltz SL. Use of a double-channel duodenoscope for diagnostic and therapeutic ERCP. Gastrointest Endosc. 1999;50:833-837.

Lee RM, Vida F, Kozarek RA, et al. In vitro and in vivo evaluation of a reusable double-channel sphincterotome. Gastrointest Endosc. 1999;49:477-482.

Lin LF, Siauw CP, Ho KS, Tung JC. ERCP in post-Billroth II gastrectomy patients: emphasis on technique. Am J Gastroenterol. 1999;94:144-148.

Mavrogiannis C, Liatsos C, Romanos A, Petuomenos C, Nakos A, Karvountzis G. Needle-knife fistulotomy versus needle-knife precut papillotomy for the treatment of common bile duct stones. Gastrointest Endosc. 1999;50:334-339.

Monig H, Arendt T, Eggers S, Kloehn S, Folsch U. Iodine absorption in patients undergoing ERCP compared with coronary angiography. Gastrointest Endosc. 1999;50:79-81.

Ramirez FC, Dennert B, Sanowski R. Success of repeat ERCP by the same endoscopist. Gastrointest Endosc. 1999;49:58-61.

Ratani RS, Mills TN, Ainley CC, Swain CP. Electrophysical factors influencing endoscopic sphincterotomy. Gastrointest Endosc. 1999;49:43-51.

Seo DW, Kim MH, Lee SK, et al. Usefulness of cholangioscopy in patients with focal stricture of the intrahepatic duct unrelated to intrahepatic stones. Gastrointest Endosc. 1999;49:204-209.

Sorbi D, Van Os EC, Alberger FJ, et al. Clinical application of a new disposable lithotripter: a prospective multicenter study. Gastrointest Endosc. 1999;49:210-213.

Suddique I, Galati J, Ankoma-Sey V, et al. The role of choledochoscopy in the diagnosis and management of biliary tract diseases. Gastrointest Endosc. 1999;50:67-73.

Wehrmann T, Kokapick S, Lembcke B, Caspart WF, Seifert H. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc. 1999;49:667-683.

Weickert U, Muhlen E, Janssen J, Johanns W, Greiner L. The thermodilator: an effective instrument in the palliative therapy concept of malignant bile duct stenosis. Endoscopy. 1999;31:260-264.

Aizawa T, Ueno N, Ozawa Y. Temporary pancreatic duct stenting to prevent pancreatitis induced by endoscopic sphincter dilation. Dig Endosc. 1999;11:32-36.

Basso N, Pizzuto G, Surgo D, et al. Laparoscopic cholecystectomy and intraoperative endoscopic sphincterotomy in the treatment of cholecysto-choledocholithiasis. Gastrointest Endosc. 1999;50:532-535.

Komatsu Y, Toda N, Isayama H, et al. Washout of small stones in the bile duct by saline infusion using a side-holed balloon catheter in patients undergoing endoscopic papillary balloon dilation. Gastrointest Endosc. 1999;49:101-104.

Lai KH, Lin LF, Lo GH, et al. Does cholecystectomy after endoscopic sphincterotomy prevent the recurrence of biliary complications? Gastrointest Endosc. 1999;49:483-487.

Ohashi A, Tamada K, Tomiyama T, et al. Influence of bile duct diameter on the therapeutic quality of endoscopic balloon sphincteroplasty. Endoscopy. 1999;31:137-141.

Ohashi A, Ueno N, Tamada K, et al. Assessment of residual bile duct stones with use of intraductal US during endoscopic balloon sphincteroplasty: comparison with balloon cholangiography. Gastrointest Endosc. 1999;49:328-333.

Sahai AV, Mauldin PD, Marsi V, Hawes RH, Hoffman BJ. Bile duct stones and laparoscopic cholecystectomy: a decision analysis to assess the roles of intraoperative cholangiography, EUS and ERCP. Gastrointest Endosc. 1999;49:334-343.

Sarli L, Pietra N, Franze A, et al. Routine intravenous cholangiography, selective ERCP, and endoscopic treatment of bile duct stones before laparoscopic cholecystectomy. Gastrointest Endosc. 1999;50:200-208.

Sugiyama M, Atomi Y. Does endoscopic papillary balloon dilation affect gallbladder motility? Gastrointest Endosc. 1999;50:74-78.

Sugiyama M, Atomi Y. Does endoscopic sphincterotomy cause prolonged pancreatobiliary reflux? Am J Gastroenterol. 1999;94:795-798.

Sugiyama M, Izumisato Y, Hatano N, Mori T, Atomi Y. Management of unsuspected common bile duct stones found during laparoscopic cholecystectomy by means of transcystic catheter placement and papillary dilation. Gastrointest Endosc. 1999;50:837-840.

Ueno N, Ozawa Y. Pancreatitis induced by endoscpic balloon sphincter dilation and changes in serum amylase levels after the procedure. Gastrointest Endosc. 1999;49:472-476.

Maldonado ME, Brady PG, Mamel JJ, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). Am J Gastroenterol. 1999;94:387-390.

Poon RTP, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999;94:593-598.

Rabenstein T, Schneider HT, Nicklas M, et al. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc. 1999;50:628-635.

Sherman S. Predicting endoscopic sphincterotomy-induced pancreatitis using serum amylase levels. Am J Gastroenterol. 1999;94:1129-1130.

Testoni PA, Bagnolo F, Caporuscio S, Lella F. Serum amylase measure four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol. 1999;94:1235-1241.

Testoni PA, Caporuscio S, Bagnolo F, Lella F. Twenty-four hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy. Endoscopy. 1999;31:131-136.

Trap S, Adensen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP. Endoscopy. 1999;31:125-130.

Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc. 1999;50:27-33.

Chaurasia OP, Rauws AJ, Fockens P, Huibregtse K. Endoscopic techniques for retrieval of proximally migrated biliary stents: the Amsterdam experience. Gastrointest Endosc. 1999;50:780-785.

Luman W, Ghosh S, Palmer KR. A combination of ciprofloxacin and Rowachol does not prevent biliary stent occlusion. Gastrointest Endosc. 1999;49:316-321.

Margulies C, Siqueira ES, Silverman WB, et al. The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses. Gastrointest Endosc. 1999;49:716-719.

Povoski SP, Karpeh MS, Conlon KC, Blumgard LH, Brennan MF. Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and morality after pancreaticoduodenectomy. Journal of Gastrointestinal Surgery. 1999;3:496-505.

Sung JJY, Sollano JD, Lai CW, et al. Long-term ciprofloxacin treatment for the prevention of biliary stent blockage: a prospective randomized study. Am J Gastroenterol. 1999;94:3197-3201.

Van Os EC, Petersen BT, Batts KP. Spiral Nitinol biliary stents in a porcine model: evaluation of the potential for use in benign strictures. Endoscopy. 1999;31:253-259.

Vandervoort J, Carr-Locke DL, Tham TCK, Wong RCK. A new technique to retrieve an intrabiliary stent: a case report. Gastrointest Endosc. 1999;49:800-802.

Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999;49:466-471.

Ademek HE, Jakobs R, Buttman A, Ademek MU, Schneider RJ, Rieman JF. Long term followup of patients with chronic pancreatitis and pancreatic stones treated with extracorporeal shock wave lithotripsy. Gut. 1999;45:402-405.

Arendt T, Nizze H, Liebe S, Erdmann K, Folsch UR. Does bile of patients with acute gallstone pancreatitis cause pancreatic inflammatory lesions? A study of the pancreatic toxicity of choledochal secretions collected at ERCP. Gastrointest Endosc. 1999;50:209-213.

Beckingham IJ, Krige EJ, Bornman PC, Terblanche J. Long term outcome of endoscopic drainage of pancreatic pseudocysts. Am J Gastroenterol. 1999;94:71-74.

Bracher GA, Manocha AP, DeBanto JR, et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc. 1999;49:710-715.

Carr-Locke DL. Endoscopic therapy of chronic pancreatitis. Gastrointest Endosc. 1999;49:S77-S80.

Howell DA, Dy RM, Hanson BL, Nezhad SF, Broaddus SB. Endoscopic treatment of pancreatic duct stones using a 10F pancreatoscope and electrohydraulic lithotripsy. Gastrointest Endosc. 1999;50:829-833.

Jacob L, Geenen JE, Catalano MF, Johnson GK, Geenen DJ, Hogan WJ. Clinical presentation and short-term outcome of endoscopic therapy of patients with symptomatic incomplete pancreas divisum. Gastrointest Endosc. 1999;49:53-57.

Nowak A, Marek TA, Nowakowski-Dulawa E, Rybicka J, Kaczor R. Biliary pancreatitis needs endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy for cure. Endoscopy. 1998;30:A256-259.

Sharma VK, Howden CW. Meta-analysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis. Am J Gastroenterol. 1999;94:3211-3214.

Desautels SG, Slivka A, Hutson WR, et al. Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. Gastroenterology. 1999;116:900-905.

Eversman D, Fogel EL, Rusche M, Sherman S, Lehman GA. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc. 1999;50:637-641.

Guelrud M, Morera C, Rodriguez M, Jean D, Pierre R. Sphincter of Oddi dysfunction in children with recurrent pancreatitis and anomalous pancreaticobiliary union: an etiologic concept. Gastrointest Endosc. 1999;50:194-199.

Kellow JE. Sphincter of Oddi dysfunction type III: another manifestation of visceral hyperalgesia? Gastroenterology. 1999;116:996-1000.

Cvetkovski B, Gerdes H, Kurtz RC. Outpatient therapeutic ERCP with endobiliary stent placement for malignant common bile duct obstruction. Gastrointest Endosc. 1999;50:63-66.

Freeman ML, Nelson DB, Sherman S, et al. Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. Gastrointest Endosc. 1999;49:580-586.

Kozarek RA. ERCP economics. Gastrointest Endosc. 1999;49:660-662.

Al-Kawas FH. Endoscopic management of primary sclerosing cholangitis: less is better. Am J Gastroenterol. 1999;94:2335-2336.

Ponsioen CY, Lam K, van Milligen WM, Huibregtse K, Tytgat GNJ. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:2403-2407.

Ponsioen CY, Vrouenraets SME, van Milligen de Wit AWM, et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy. 1999;31:305-309.

Stiehl A. Value of brush border cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy. 1999;31:333-334.

Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc. 1999;49:358-364.

Dhiman RK, Puri P, Chawla Y, et al. Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? Gastrointest Endosc. 1999;50:646-652.

Dowidar N, El Saayad M, Osman M, Salen A. Endoscopic therapy of fascioliasis resistant to oral therapy. Gastrointest Endosc. 1999;50:345-351.

Dumas R, Le Gall P, Hastier P, Buckley MJM, Conio M, Delmont JP. The role of endoscopic retrograde cholangiopancreatography in the management of hepatic hydatid disease. Endoscopy. 1999;31:253-259.

Guelrud M, Morera C, Rodriguez M, Prados JG, Jaen D. Normal and anomalous pancreaticobiliary union in children and adolescents. Gastrointest Endosc. 1999;50:189-193.

Lam YH, Wong SKH, Lee DWH, et al. ERCP and pyogenic liver abscess. Gastrointest Endosc. 1999;50:340-344.

Majeed AW, Ross B, Johnson AG. The preoperatively normal bile duct does not dilate after cholecystectomy: results of a five year study. Gut. 1999;45:741-743.

Malkan GH, Bhatia SJ, Bashir K, et al. Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications. Gastrointest Endosc. 1999;49:344-348.

Mavrogiannis C, Liatsos C, Romanos A, et al. Sump syndrome: endoscopic treatment and late recurrence. Am J Gastroenterol. 1999;94:972-975.

Mergener K, Strobel JC, Suhocki P, et al. The role of ERCP in diagnosis and management of accessory bile duct leaks after cholecystectomy. Gastrointest Endosc. 1999;50:527-531.

Samavedy R, Sherman S, Lehman GA. Endoscopic therapy in anomalous pancreatobiliary duct junction. Gastrointest Endosc. 1999;50:623-627.

Saurin JC, Chayvialle JA, Ponchon T. Management of duodenal adenomas in familial adenomatous polyposis. Endoscopy. 1999;31:472-478.

Wilkinson ML. Are dilating bile ducts a cause for concern? Gut. 1999;45:637-638.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: